The post-test for this issue is available for one year after the publication date to subscribers. By successfully completing the test you will be awarded a certificate for 1 CME credit.
Read More
Trazodone is rarely used as an antidepressant, and that’s a missed opportunity. It lacks the weight gain, sleep disruption, and sexual side effects that so many antidepressants cause. In this article are two important dosing tips that can make it work better.
Read More
“Don’t think of it as telepsychiatry, think of it as a home visit,” says Peter Yellowlees as he teaches us how to create more meaningful interactions through the digital screen. Dr. Yellowlees covers many of the dicey details of this medium: Involuntary hospitalization, interstate regulations, medical notes, billing, and how to set up the equipment on a budget are all inside.
Read More
The FDA recently raised alerts about a potentially fatal side effect on clozapine that’s causing more fatalities than neutropenia. It’s constipation, and the problem extends to a few other psychotropics as well. In this article, a three step, evidence-based algorithm for managing it.
Read More
When researchers at the Department of Veteran Affairs found a 61% increase in suicide attempts when veterans took trazodone vs. zolpidem for sleep, the story made headlines. We tease apart the strengths and weaknesses of this 350,000 subject study to see what the real risk is.
Read More
Dr. Aiken is the Editor in Chief of The Carlat Psychiatry Report; director of the Mood Treatment Center in North Carolina, where he maintains a private practice combining medication and therapy along with evidence-based complementary and alternative treatments; and Assistant Professor NYU Langone Department of Psychiatry. He has worked as a research assistant at the NIMH and a sub-investigator on clinical trials, and conducts research on a shoestring budget out of his private practice. Follow him on Twitter and find him on LinkedIn.